4Rajan K. Verma,Divi Murali Krishna,Sanjay Garg. Formulation aspects in the development of osmotically controlled oral drug delivery systems.Journal of Controlled Release,2002,79:7-27.
5Kazuto Okimoto,Yuji Tokunag,Rinta Ibuki. Applicability of (SBE) 7m-β-CD in controlled-porosity, osmotic.pump.tablets.International Journal of Pharmaceutics,2004,286:81-88.
6D.Prabakaran, Paramjit Singh.Effect of hydrophilic polymers on the release of dihiazem hydrochloride from elementary osmotic pumps. International Journal of Pharmaceutics,2003,259:173- 179.
9Mcclelland GA,Sutton SC,Engle K et al.Pharm Enhancement of hydroxymethylglutaryl coenzyme A (HMG2CoA) redutase inhibitor efficacy through administration of a controlled porosity osmotic pump dosage form.Pharm Res,1991,8(7):873.
3Vincent M, Joerg O, Nicoletta L, et al. Oral osmotically driven systems: 30 years of development and clinical use [J]. Eur J Pharm Biopharm, 2009, 73(3): 311-323.
4Tzahi C, Amy C, Menachem E. Forward osmosis: principles, applications, and recent developments [J]. J Membrane Sci, 2006, 281: 70-87.
5Kumar G, Gupta D. Development and in vitro evaluation of smotically controlled oral drug delivery system of carvedilol [J]. Int J Pharm Sci Drug Res, 2009, 1(2): 80- 82.
6Liu, Yang X G, Nie S F, et al. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and investigation [J]. Int J Pharm, 2007, 332:115-124.
7Wang C, Chen F, Li J Z, et al. A novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system [J]. Pharm Soc Jpn, 2008, 128(5): 773-782.
8Shahla J, Reza F. Development of a controlled release low dose class Ⅱ drug-Glipizide [J]. Int J Pharm, 2006, 312:24-32.
9Rao P B, Geethal M, Purushothama N, et al. Optimization and development of swellable controlled porosity osmotic pump tablet for theophylline [J]. Trop J Pharm Res, 2009, 8 (3): 247-255.
10Mahalaxmi R, Phanidhar S, Ravi K, et al. Enhancement of dissolution of glipizide from controlled porosity osmotic pump using a wicking agent and a solubilizing agent [J]. Int J Pharm Tech Res, 2009, 1(3): 705-711.
